Pentwater Capital Management LP Oyster Point Pharma, Inc. Transaction History

Pentwater Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $793,650 - $1.63 Million	-92,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.13 - $25.18 $45,325 - $62,950	2,500 Added 2.78%	92,500 $1.74 Million
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $1.95 Million - $2.52 Million	70,000 Added 350.0%	90,000 $2.6 Million
Q1 2020 May 15, 2020	BUY	$23.65 - $40.96 $227,040 - $393,216	9,600 Added 92.31%	20,000 $700,000
Q4 2019 Feb 14, 2020	BUY	$13.55 - $26.15 $140,920 - $271,960	10,400 New	10,400 $254,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.